Browsing by Author Tsimihodimos, V.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 61 to 74 of 74 < previous 
TitleAuthor(s)Issue date???itemlist.???
Plasma lipoproteins and triacylglycerol are predictors of small, dense LDL particlesTsimihodimos, V.; Gazi, I.; Kostara, C.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Plasma triglyceride levels and body mass index values are the most important determinants of pre beta-1 HDL concentrations in patients with various types of primary dyslipidemiaTsimihodimos, V.; Gazi, I.; Filippatos, T.; Kostapanos, M.; Lagos, K.; Kostara, C.; Tellis, C. C.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic ProfileFilippatos, T.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Pleiotropic effects of ezetimibe: do they really exist?Kalogirou, M.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Pleiotropic effects of fenofibrateTsimihodimos, V.; Liberopoulos, E.; Elisaf, M. S.24-Nov-2015-
The PON1 M55L gene polymorphism is associated with reduced HDL-associated PAF-AH activityKakafika, A. I.; Xenofontos, S.; Tsimihodimos, V.; Tambaki, A. P.; Lourida, E. S.; Kalaitzidis, R.; Cariolou, M. A.; Elisaf, M.; Tselepis, A. D.24-Nov-2015-
Possible mechanisms of the fibrate-induced increase in serum creatinineTsimihodimos, V.; Miltiadous, G.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Prediabetes: to treat or not to treat?Moutzouri, E.; Tsimihodimos, V.; Rizos, E.; Elisaf, M. S.24-Nov-2015-
Reduced levels of HDL-associated PAF-acetylhydrolase activity in normolipidemic and dyslipidemic PON1 55LL carriersKakafika, A.; Tambaki, A.; Lourida, E.; Xenofontos, S.; Tsimihodimos, V.; Kalaitzidis, R.; Cariolou, M.; Elisaf, M.; Tselepis, A.24-Nov-2015-
A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular diseaseKei, A. A.; Filippatos, T. D.; Tsimihodimos, V.; Elisaf, M. S.24-Nov-2015-
Risk factors for cardiovascular and renal disease in hypertensivesKalaitzidis, R.; Tsimihodimos, V.; Bairaktari, E.; Milionis, H.; Elisaf, M. S.; Siamopoulos, K. C.24-Nov-2015-
Salicylate-induced proximal tubular dysfunctionTsimihodimos, V.; Psychogios, N.; Kakaidi, V.; Bairaktari, E.; Elisaf, M. S.24-Nov-2015-
Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndromeFilippatos, T. D.; Tsimihodimos, V.; Kostapanos, M.; Kostara, C.; Balraktari, E. T.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Therapy with statins is effective in some patients with homozygous familial hypercholesterolemiaTsimihodimos, V.; Miltiadous, G.; Elisaf, M. S.24-Nov-2015-